Ledger.Open graph →
SEC Form D · filed September 4, 2025

PharmaCyte Biotech, Inc

Offering
$7.0M
Sold
$7.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LAS VEGAS, NV
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Walker R. Wayne · LAS VEGAS, NVDirectorCarlos N. Trujillo · LAS VEGAS, NVExecJonathan L. Schechter · New York, NYDirectorJoshua N. Silverman · New York, NYExec · DirectorJonathan L. Schechter · New York, NYDirectorRobert M. Weinstein · LAS VEGAS, NVDirectorMichael M. Abecassis · Laguna Hills, CADirectorWalker R. Wayne · LAS VEGAS, NVDirectorCarlos N. Trujillo · LAS VEGAS, NVExecMichael M. Abecassis · Laguna Hills, CADirectorRobert M. Weinstein · LAS VEGAS, NVDirectorJoshua N. Silverman · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗